I agree that this site is using cookies. You can find further informations here.
X
Kenna, J. Gerry
79  results:
Search for persons X
?
1

Use of In Vivo Imaging and Physiologically-Based Kinetic Mo..:

Melillo, Nicola ; Scotcher, Daniel ; Kenna, J. Gerry...
Pharmaceutics.  15 (2023)  3 - p. 896 , 2023
Link: https://doi.org/10.3390/..
 
?
2

The role of a molecular informatics platform to support nex..:

Yang, Chihae ; Rathman, James F ; Bienfait, Bruno...
Computational Toxicology.  26 (2023)  - p. 100272 , 2023
Link: https://doi.org/10.1016/..
 
?
3

A 10-step framework for use of read-across (RAX) in next ge..:

Alexander-White, Camilla ; Bury, Dagmar ; Cronin, Mark...
Regulatory Toxicology and Pharmacology.  129 (2022)  - p. 105094 , 2022
Link: https://doi.org/10.1016/..
 
?
4

Read-across and new approach methodologies applied in a 10-..:

Ouedraogo, Gladys ; Alexander-White, Camilla ; Bury, Dagmar...
Regulatory Toxicology and Pharmacology.  132 (2022)  - p. 105161 , 2022
Link: https://doi.org/10.1016/..
 
?
5

Use of in vitro metabolism and biokinetics assays to refine..:

Hewitt, Nicola J. ; Troutman, John ; Przibilla, Julia...
Regulatory Toxicology and Pharmacology.  131 (2022)  - p. 105132 , 2022
Link: https://doi.org/10.1016/..
 
?
6

New framework for a non-animal approach adequately assures ..:

Bury, Dagmar ; Alexander-White, Camilla ; Clewell III, Harvey J....
Regulatory Toxicology and Pharmacology.  123 (2021)  - p. 104931 , 2021
Link: https://doi.org/10.1016/..
 
?
7

SC1.4 - Can BSEP inhibition testing in drug discovery and d..:

Kenna, Gerry
Drug Metabolism and Pharmacokinetics.  35 (2020)  1 - p. S1-S2 , 2020
Link: https://doi.org/10.1016/..
 
?
8

Safety Assessment of Pharmaceuticals:

, In: The History of Alternative Test Methods in Toxicology,
Kenna, J Gerry ; Ram, Rebecca - p. 167-176 , 2019
Link: https://doi.org/10.1016/..
 
?
9

Contributors:

, In: The History of Alternative Test Methods in Toxicology,
Austin, Christopher P. ; Balls, Michael ; Blaauboer, Bas J.... - p. xv-xvi , 2019
Link: https://doi.org/10.1016/..
 
?
10

Advancing nonclinical innovation and safety in pharmaceutic..:

Baker, Elizabeth J. ; Beck, Nancy A. ; Berg, Ellen L....
Drug Discovery Today.  24 (2019)  2 - p. 624-628 , 2019
Link: https://doi.org/10.1016/..
 
?
11

Can Bile Salt Export Pump Inhibition Testing in Drug Discov..:

Kenna, J. Gerry ; Taskar, Kunal S. ; Battista, Christina...
Clinical Pharmacology & Therapeutics.  104 (2018)  5 - p. 916-932 , 2018
Link: https://doi.org/10.1002/..
 
?
12

DILI: What is the problem?:

Kenna, Gerry
Drug Metabolism and Pharmacokinetics.  32 (2017)  1 - p. S2 , 2017
Link: https://doi.org/10.1016/..
 
?
13

Integrating DILI hazards enables prediction, assessment, an..:

Kenna, Gerry
Drug Metabolism and Pharmacokinetics.  32 (2017)  1 - p. S3 , 2017
Link: https://doi.org/10.1016/..
 
?
14

Improved hepatic physiology in hepatic cytochrome P450 redu..:

Akingbasote, James A. ; Foster, Alison J. ; Jones, Huw B....
Toxicology Research.  6 (2017)  1 - p. 81-88 , 2017
Link: https://doi.org/10.1039/..
 
?
15

Key Challenges and Opportunities Associated with the Use of..:

Atienzar, Franck A. ; Blomme, Eric A. ; Chen, Minjun...
BioMed Research International.  2016 (2016)  - p. 1-20 , 2016
Link: https://doi.org/10.1155/..
 
1-15